Genoway Valuation

ALGEN Stock  EUR 2.49  0.04  1.63%   
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Genoway retains a regular Real Value of €2.07 per share. The prevalent price of the firm is €2.49. Our model calculates the value of Genoway from evaluating the firm fundamentals such as Return On Asset of 0.0136, current valuation of 43.08 M, and Return On Equity of 0.0712 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Genoway's valuation include:
Price Book
1.6707
Enterprise Value
43.1 M
Enterprise Value Ebitda
8.3893
Price Sales
1.1312
Trailing PE
13.8333
Overvalued
Today
2.49
Please note that Genoway's price fluctuation is very risky at this time. Calculation of the real value of Genoway is based on 3 months time horizon. Increasing Genoway's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Genoway's intrinsic value may or may not be the same as its current market price of 2.49, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.49 Real  2.07 Hype  2.48
The intrinsic value of Genoway's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Genoway's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.07
Real Value
5.76
Upside
Estimating the potential upside or downside of Genoway helps investors to forecast how Genoway stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genoway more accurately as focusing exclusively on Genoway's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.122.486.17
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Genoway's intrinsic value based on its ongoing forecasts of Genoway's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Genoway's closest peers.

Genoway Cash

4.03 Million

About Genoway Valuation

The stock valuation mechanism determines Genoway's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Genoway based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genoway. We calculate exposure to Genoway's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Genoway's related companies.
Last ReportedProjected for Next Year
Gross Profit-1.7 M-1.6 M
Pretax Profit Margin(0.10)(0.10)
Operating Profit Margin 0.09  0.10 
Net Profit Margin 0.07  0.08 
Gross Profit Margin(0.10)(0.09)

Additional Tools for Genoway Stock Analysis

When running Genoway's price analysis, check to measure Genoway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genoway is operating at the current time. Most of Genoway's value examination focuses on studying past and present price action to predict the probability of Genoway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genoway's price. Additionally, you may evaluate how the addition of Genoway to your portfolios can decrease your overall portfolio volatility.